Advanced search
Showing result 1 - 5 of 17 swedish dissertations matching the above criteria.
-
1. Parkinson’s disease and depression : clinical and neurobiological studies
Abstract : Parkinson´s disease (PD) is a progressive degenerative movement disorder. PD patients also suffer from several non-motor symptoms including autonomic disturbances, cognitive decline and neuropsychiatric conditions. READ MORE
-
2. CSF biomarkers reflecting beta-amyloid and axonal pathology in Alzheimer's disease and related conditions
Abstract : Cerebrospinal fluid (CSF) biomarkers may be used to identify and monitor pathological processes in the central nervous system. CSF biomarkers in Alzheimer’s disease (AD) include β-amyloid 42 (Aβ42), total-tau (T-tau) and phosphorylated-tau (P-tau), reflecting brain amyloid, axonal and tangle pathology, respectively. READ MORE
-
3. Acute Symptomatic Seizure : Clinical and Experimental Studies
Abstract : Epilepsy is defined as a condition with recurrent unprovoked seizures. When seizures are believed to be provoked they fall into another category of situation related seizures, i.e. acute symptomatic seizures (ASS). READ MORE
-
4. Acute Symptomatic Seizures : Clinical and Experimental Studies
Abstract : Epilepsy is defined as a condition with recurrent unprovoked seizures. When seizures are believed to be provoked they fall into another category of situation-related seizures, i.e. acute symptomatic seizures (ASS). READ MORE
-
5. Biomarkers for Alzheimer's disease and the APOE polymorphism
Abstract : Alzheimer’s disease (AD) is the most common form of dementia and cerebrospinal fluid (CSF) biomarkers reflecting the core pathology of AD are now widely used for diagnosis making, in particular β-amyloid[1-42] (Aβ42) reflecting amyloid plaque pathology, phosphorylated tau (P-tau) reflecting neurofibrillary tangle pathology and total tau (T-tau) reflecting general neurodegeneration. In addition, blood-based biomarkers for AD are in the pipeline with recent studies showing promising diagnostic potential. READ MORE